Upstream Bio (UPB) Share-based Compensation (2023 - 2026)
Upstream Bio (UPB) recorded Share-based Compensation of $4.35 million in Q2 2026, up 67.7% from $2.6 million a year earlier but down 6.3% from the prior quarter.
Powered by 
Analysis
Upstream Bio (UPB) Share-based Compensation (2023 - 2026) Analysis & Trends
On a TTM basis, Upstream Bio's Share-based Compensation came in at $14.1 million as of Jun 30, 2026, up 53.6% year-over-year; for FY2025, it was $10.33 million, up 72.1% from FY2024.
- Across earlier years, Share-based Compensation came in at $6 million in FY2024 (+80.6%) and $3.33 million in FY2023.
- Quarterly Share-based Compensation has ranged from $643,000 in Q1 2024 to $4.65 million in Q1 2026 over the past five years.
- On a year-over-year basis, Share-based Compensation has increased for seven consecutive quarters, with growth averaging 112.9% over the last seven quarters.
- Per Business Quant, the preceding three quarters came in at $4.65 million (Q1 2026), $2.51 million (Q4 2025) and $2.59 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Upstream Bio | 185.26 Mn | -919.50 Mn | - | 4.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.35 Mn |
| Jun 30, 2026 | 4.35 Mn |
| Mar 31, 2026 | 4.65 Mn |
| Dec 31, 2025 | 2.51 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 2.60 Mn |
| Mar 31, 2025 | 2.64 Mn |
| Dec 31, 2024 | 2.09 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 643,000.00 |
| Dec 31, 2023 | 813,000.00 |
| Sep 30, 2023 | 683,000.00 |
API Access
Upstream Bio Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=UPB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "UPB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=UPB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();